Lupus health registry that stores samples for future research
Part of Brain & nervous system, Heart & circulation, Immune system & allergy, Infections, Kidney & urinary, Skin, Women’s health & pregnancy clinical trials.
This study keeps a long-term record of people with lupus (systemic lupus erythematosus) and collects samples so researchers can study the disease better. You may be able to join if you meet lupus diagnosis criteria, are not pregnant, and can follow the study visits and consent process.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be able to understand the study and sign the consent form
- Be 18 years old or older
- Have a lupus diagnosis that matches recognized lupus criteria or a clinician confirms lupus
- Be able to attend required study visits and complete study procedures
- Not be pregnant when you enroll
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study creates a registry for people with lupus and their families. It helps researchers learn more about lupus and improve care. You or your child can join if you have a lupus diagnosis.
This study follows people newly diagnosed with lupus (SLE) to understand how the disease develops over time. It looks at what happens before treatment starts or soon after diagnosis, and aims to improve care for lupus patients across Europe.
This study aims to find better ways to detect kidney problems in people with lupus by testing blood and urine samples. If you have lupus, you may help researchers improve how kidney disease is diagnosed and monitored.
This study looks at blood and immune cell markers (autoantibodies and immune cell “signatures”) to better understand autoimmune conditions, including lupus. It may help researchers identify which markers are linked to disease and how immune cells respond after vaccination.
This study creates a registry for people with systemic lupus erythematosus (SLE) to track the disease over time. Joining helps researchers learn more about lupus and may improve care for future patients.
This registry tracks the safety and effectiveness of lupus treatments over time. If you have SLE and are starting a new treatment or were recently diagnosed, joining helps doctors learn which medicines work best.
Hear when a new Lupus Nephritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.